1. Search Result
Search Result
Results for "

2365172-42-3

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-130604
    DT2216

    PROTACs Apoptosis Cancer
    DT2216 is a potent and selective BCL-XL degrader based on PROTAC technology. DT2216 causes effective degradation of BCL-XL protein by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase. DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets.